Pituitary

Article	Citations
Lateral orientation of Rathke cleft cysts may be associated with high rates of recurrence after surgery	77
Low prevalence of neuropathic-like pain symptoms in long-term controlled acromegaly	46
Cushing’s disease: adrenal steroidogenesis inhibitors	34
POU1F1 mutations in combined pituitary hormone deficiency: differing spectrum of mutations in a Western-Indian cohort and systematic analysis of world literature	32
Cushing’s disease: role of bilateral adrenalectomy	29
Medical therapy for refractory pituitary adenomas	29
Evaluation of cardiac structure, exercise capacity and electrocardiography parameters in children with partial and complete growth hormone deficiency and their changes with short term growth hormone r	28
Importance of 24 h ambulatory blood pressure monitoring in patients with acromegaly and correlation with cardiac magnetic resonance findings	27
GnRH agonist-associated pituitary apoplexy: a case series and review of the literature	25
Patient-reported outcomes in refractory hormone-producing pituitary adenomas: an unmet need	24
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas	22
Lymphocytic panhypophysitis and anti-rabphilin-3A antibody with pulmonary sarcoidosis	20
Measuring pituitary tumor volume: a comparison of the simplified and non-simplified ellipsoid equation with the 3D planimetric volume assessment	19
The efficacy of a visiting surgical service versus that of a hospital-based surgical service in providing endoscopic endonasal surgery to remove nonfunctioning pituitary adenomas in rural communities	19
The microenvironment of pituitary adenomas: biological, clinical and therapeutical implications	17
The impact of facility type and volume on treatment and overall survival in craniopharyngioma	17
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency	17
Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) study	17
Demonstration of the inferior intercavernous sinus is closely linked to the extent of pneumatization of the sphenoid sinus: useful information for the pituitary surgeon	17
An Infundibular Unidentified Object (IUO): a new pituitary stalk marker?	17
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours	16
Diffusion-weighted imaging does not seem to be a predictor of consistency in pituitary adenomas	16
Changing the name of diabetes insipidus	16
Pituitary stalk interruption syndrome: phenotype, predictors, and pathophysiology of perinatal events	16
Hypercoagulability in Cushing’s syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols	16

Pituitary apoplexy score, toward standardized decision-making: a descriptive study	16
Predictors of biochemical remission after transsphenoidal surgery in a large cohort of acromegaly patients	15
Reported outcomes in transsphenoidal surgery for pituitary adenomas: a systematic review	15
Delayed postoperative hyponatremia in patients with acromegaly: incidence and predictive factors	15
Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers	15
A study on clinical outcomes of Rathke’s cleft cyst in patients managed conservatively	15
Proportion and predictors of Hypogonadism Recovery in Men with Macroprolactinomas treated with dopamine agonists	14
Treatment and prognostic factors of pituicytoma: a single-center experience and comprehensive literature review	14
A comparison of macular ganglion cell and retinal nerve fibre layer optical coherence tomographic parameters as predictors of visual outcomes of surgery for pituitary tumours	14
Pituitary tumor centers of excellence (PTCOE): the next border of acromegaly treatment	14
Assessment of forearm muscles with ultrasound shear wave elastography in patients with acromegaly	14
Influence of growth hormone therapy on germinoma survivors	14
Comparison between extended transsphenoidal and transcranial surgery for craniopharyngioma: focus on hypothalamic function and obesity	14
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience	13
Semaglutide treatment of hypothalamic obesity – a real-life data study	13
Growth hormone increase by luteinizing hormone-releasing hormone reflects gonadotroph-related characteristics in acromegaly	13
When to decide on testosterone replacement despite dopamine agonist therapy in male prolactinomas?	13
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma	13
Growth hormone secreting pituitary adenomas show distinct extrasellar extension patterns compared to nonfunctional pituitary adenomas	12
Machine learning models predict delayed hyponatremia post-transsphenoidal surgery using clinically available features	12
Recovery from hypogonadism in men with prolactinoma treated with dopamine agonists	12
Surgical treatment of cystic pituitary adenomas: literature-based definitions and postoperative outcomes	12
Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans	11
Substance P and Neurokinin-1 receptor are overexpressed in adamantinomatous craniopharyngioma than in the pituitary gland	11
Historical and future trends in emergency pituitary referrals: a machine learning analysis	11
The impact of non-clinical factors in pituitary surgery	11
Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results	10
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States	10
Diabetes insipidus after endoscopic transsphenoidal surgery: multicenter experience and development of the SALT score	10
Skeletal fragility in pituitary disease: how can we predict fracture risk?	10
Posterior hypothalamic involvement on pre-operative MRI predicts hypothalamic obesity in craniopharyngiomas	9
Pituitary metastases: a case series and scoping review	9
Inflammation of adenohypophysis is commonly associated with headache in surgically managed Rathke’s cleft cysts	9
Functioning gonadotroph adenomas in premenopausal women: clinical and molecular characterization and review of the literature	9
Cushing’s disease: role of preoperative and primary medical therapy	9
High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma	9
Prolactin immunoassay: does the high-dose hook effect still exist?	9
An update on, and genetics of refractory adenomas of childhood	9
Correction: Giant prolactinomas, a detailed analysis of 196 adult cases	9
Thyrotropin-secreting pituitary adenomas induce left atrial enlargement with subclinical atrial fibrillation: an echocardiographic study	8
Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2	8
Effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: an updated systematic review and meta-analysis	8
Novel approach to bone comorbidity in resistant acromegaly	8
Giant prolactinomas, a detailed analysis of 196 adult cases	8
A patient-reported outcome measure for patients with pituitary adenoma undergoing transsphenoidal surgery	8
Pituitary: hic manebimus optime	8
Can we predict the risk of venous thromboembolism in patients with Cushing’s syndrome: a nationwide cohort analysis	8
Problem-solving therapy can reduce psychological distress in patients with Cushing’s disease: a randomized controlled trial	8
Neuropathic foot ulcers in the tallest patients with acromegalic gigantism: a common and significant problem. Historical overview	8
Second-line regimen for CNS-involved pediatric Langerhans cell histiocytosis	8

Changes in pituitary adenoma patient presentation and outcomes during the COVID pandemic at a Pituitary Center of Excellence	8
Symptoms and steroid dose adjustments following the Covid-19 vaccine in patients with adrenal insufficiency	8
TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours	7
Pituitary apoplexy and panhypopituitarism following acute leptospirosis	7
High prevalence of overweight/obesity and dyslipidemia in patients with intracranial germ cell tumors	7
Cushing’s syndrome in women: age-related differences in etiology and clinical picture	7
HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency	7
Radiological evolution of autograft fat used for skull base reconstruction after transsphenoidal surgery for pituitary adenomas	7
11C-methionine PET aids localization of microprolactinomas in patients with intolerance or resistance to dopamine agonist therapy	7
Overnight 1 mg dexamethasone suppression test and 24 h urine free cortisol—accuracy and pitfalls when screening for Cushing’s syndrome	7
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience	7
Changes in multi-modality management of acromegaly in a tertiary centre over 2 decades	7
Evaluating the burden of endogenous Cushing’s syndrome using a web-based questionnaire and validated patient-reported outcome measures	7
Implementation of functional imaging using 11C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery	7
Impact of etiology, sex, diabetes mellitus and remission status on erythrocytic profile in patients with cushing’s syndrome: a large population database study	7
Complications and mortality of Cushing’s disease: report on data collected over a 20-year period at a referral centre	7
Gigantism: microsurgical treatment by transsphenoidal approach and prognostic factors	7
Postsurgical outcomes of nonfunctioning pituitary adenomas: a patient-level meta-analysis	7
Refractory lactotroph adenomas	6
Double adenomas of the pituitary reveal distinct lineage markers, copy number alterations, and epigenetic profiles	6
Treatment of acromegaly-induced diabetes: an updated proposal	6
Acromegaly and pregnancy: a systematic review and meta-analysis	6
Refractory pituitary adenomas: preface	6
Machine learning as a clinical decision support tool for patients with acromegaly	6
Different patient versus provider perspectives on living with Cushing’s disease	6
Neural network modeling for prediction of recurrence, progression, and hormonal non-remission in patients following resection of functional pituitary adenomas	6
Venous thromboembolism chemical prophylaxis after endoscopic trans-sphenoidal pituitary surgery	6
Long-term safety of gamma knife radiosurgery (SRS) for acromegaly	6
Endoscopic endonasal marsupialization of rathke cleft cysts: clinical outcomes and risk factors analysis of visual impairment, pituitary dysfunction, and CSF leak	6
Complication avoidance protocols in endoscopic pituitary adenoma surgery: a retrospective cohort study in 514 patients	6
Basal cortisol in relation to metyrapone confirmation in predicting adrenal insufficiency after pituitary surgery	6
The treatment of aggressive prolactinomas with everolimus	6
Vertebral fractures in patients with non-functioning pituitary adenomas - a new frontier?	6
Discrimination between non-functioning pituitary adenomas and hypophysitis using machine learning methods based on magnetic resonance imaging‑derived texture features	6
Acute elevation of interleukin 6 and matrix metalloproteinase 9 during the onset of pituitary apoplexy in Cushing’s disease	6
The role of the dentist and orthodontist in recognizing oro-facial manifestations of acromegaly: a questionnaire-based study	6
Prevalence of coronary calcium deposits in Sheehan’s syndrome patients on long term replacement treatment	6
Acromegaly increases depressive symptoms and reduces quality of life of cohabitants	6
Predictive factors of postoperative diabetes insipidus in 333 patients undergoing transsphenoidal surgery for non-functioning pituitary adenoma	5
Cardiovascular risk and glucocorticoids: a Dutch National Registry of growth hormone treatment in adults with growth hormone deficiency analysis	5
Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile	5
Growth hormone (GH) deficiency and GH replacement therapy in patients previously treated for Cushing’s disease	5
Predicting hypogonadotropic hypogonadism persistence in male macroprolactinoma	5
Glucocorticoid receptor blockers	5
The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency	5
Consensus on criteria for acromegaly diagnosis and remission	5
Glucose metabolism, gut-brain hormones, and acromegaly treatment: an explorative single centre descriptive analysis	5
How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)	5
Sleep disruption in patients with active and treated endogenous Cushing’s syndrome	5
Natural history of untreated microprolactinomas	5
Sheehan syndrome: a current approach to a dormant disease	5
Virtual magnetic resonance elastography has the feasibility to evaluate preoperative pituitary adenoma consistency	5
Correction: consensus on criteria for acromegaly diagnosis and remission	5
How to manage intolerance to dopamine agonist in patients with prolactinoma	4
Refractory somatotroph adenomas	4
Modern imaging in Cushing’s disease	4
Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomas	4
A fond farewell	4
IGF-1 is positively associated with BMI in patients with acromegaly	4
The acromegaly treatment satisfaction questionnaire (Acro-TSQ): turkish adaptation, validity, and reliability study	4
Appearance of fluid content in Rathke’s cleft cyst is associated with clinical features and postoperative recurrence rates	4
Impact of patient-reported nasal symptoms on quality of life after endoscopic pituitary surgery: a prospective cohort study	4
Impact of intraoperative magnetic resonance imaging on gross total resection, extent of resection, and residual tumor volume in pituitary surgery: systematic review and meta-analysis	4
Pituitary surgery in Cushing’s disease: first line treatment and role of reoperation	4
Dabrafenib as a diagnostic and therapeutic strategy for the non-surgical management of papillary craniopharyngioma	4
The diagnosis and prevalence of hypoprolactinemia in patients with panhypopituitarism and the effects on depression and sexual functions	4
Predictive value of macular ganglion cell-inner plexiform layer thickness in visual field defect of pituitary adenoma patients: a case-control study	4
Real-world experience with pasireotide-LAR in resistant acromegaly: a single center 1-year observation	4
Normative data for pituitary size and volume in the general population between 50 and 66 years	4
Mice with gene alterations in the GH and IGF family	4
Differences between immunotherapy-induced and primary hypophysitis—a multicenter retrospective study	4
Characteristics and overall survival in pediatric versus adult pituitary adenoma: a National Cancer Database analysis	4
Cardiovascular health and mortality in Cushing’s disease	4
Surgically treated acromegaly patients have a similar quality of life whether controlled by surgery or requiring additional medical therapy (QuaLAT Study)	4
Vascular anomalies in patients with growth hormone-secreting pituitary adenomas: illustrative case report and systematic review of the literature	4
Diagnosis and treatment outcomes of Cushing’s disease during pregnancy	3
UK practice on incidentally detected non-functioning pituitary microadenomas: analysis of two national surveys during a 12-year interval	3
Opioids and pituitary function: expert opinion	3
Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers	3
Predicting tumor consistency and extent of resection in non-functioning pituitary tumors	3

Clinical use of [18F]fluoro-ethyl-L-tyrosine PET co-registered with MRI for localizing prolactinoma remnants	3
Clinical and imaging findings for the evaluation of large Rathke’s cleft cysts and cystic craniopharyngiomas	3
Antiplatelet and anticoagulation therapy and the risk of pituitary apoplexy in pituitary adenoma patients	3
Exploring potential influencing factors of inadherence to specialist aftercare and long-term medication in patients with acromegaly	3
Pituitary metastases from neuroendocrine neoplasms: case report and narrative review	3
A prospective study on the efficacy of oral estrogen in female patients with acromegaly	3
Treatment of recurrent and persistent Cushing’s disease after first transsphenoidal surgery: lessons learned from an international meta-analysis	3
Shared decision-making and detection of comorbidities in an online acromegaly consultation with and without the Acromegaly Disease Activity Tool ACRODAT® using the simulated person approach	3
Quality of life impairment after a diagnosis of Cushing’s syndrome	3
Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease	3
Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas	3
Glucocorticoid use in patients with adrenal insufficiency following administration of the COVID-19 vaccine: a pituitary society statement	3
Is semaglutide a target therapy for acquired hypothalamic obesity?	3
Does size really matter? A closer look at the absolute size of growth hormone-secreting pituitary adenomas	3
Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results	2
Precocious puberty, pandemic and beyond	2
Acromegaly and COVID-19, lessons, and new opportunities	2
Correction: Utility of copeptin in predicting non-pathological postoperative polyuria in patients affected by acromegaly undergoing pituitary neurosurgery	2
The comprehensive evaluation of oral and fecal microbiota in patients with acromegaly	2
Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study	2
Correction: Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?	2
Cardiovascular risk in patients with acromegaly vs. non-functioning pituitary adenoma following pituitary surgery: an active-comparator cohort study	2
Giant prolactinoma in children and adolescents: a single-center experience and systematic review	2
Characteristics of inflammatory and infectious diseases of the pituitary gland in patients undergoing transsphenoidal surgery	2
Medical management pathways for Cushing’s disease in pituitary tumors centers of excellence (PTCOEs)	2
Syndrome of inappropriate antidiuresis/hyponatremia in COVID-19	2
Hypopituitarism and COVID-19	2
Long-term metabolic effectiveness and safety of growth hormone replacement therapy in patients with adult growth hormone deficiency: a single-institution study in Japan	2
Somapacitan-induced reversible lipoatrophy in an adult woman with hypopituitarism	2
Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?	2
TSH-secreting pituitary adenomas and bone	2
Correction: Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study	2
“Intrasellar tumor-to-tumor metastasis: A single center experience with a systematic review”	2
Prevalence of Nelson’s syndrome after bilateral adrenalectomy in patients with cushing’s disease: a systematic review and meta-analysis	2
Generating novel pituitary datasets from open-source imaging data and deep volumetric segmentation	2
Glucose intolerance in acromegaly is driven by low insulin secretion; results from an intravenous glucose tolerance test	2
Hypophysitis in COVID-19: a systematic review	2
Primary sellar melanocytoma	2
SARS-CoV-2 infection and vaccination in patients with pituitary diseases: the experience of a Brazilian reference center	2
Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes	2
Correction: Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders	2
Desmopressin dose requirements in patients with permanent arginine vasopressin deficiency: a tertiary center experience	2
Cushing’s disease and bone	2
Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies	2
Clinicopathological analysis of non-functioning pituitary adenomas (PAs) according to the 2022 WHO classification	2
Efficacy and safety of pasireotide treatment in acromegaly: A systematic review and single arm meta-analysis	2
Regional genotypic variations in normosmic congenital hypogonadotropic hypogonadism: our experience and systematic review	2
The diverging role of O-GlcNAc transferase in corticotroph and somatotroph adenomas	2
Risk of impulse control disorders in patients with Cushing’s disease: do not blame cabergoline but do not give up caution	2